Mutational variant allele frequency profile as a biomarker of response to immune checkpoint blockade in non-small cell lung Cancer.
Ruyun GaoNing LouLin LiTongji XiePuyuan XingLe TangJiarui YaoXiaohong HanYuan-Kai ShiPublished in: Journal of translational medicine (2024)
The mutational VAF profile is a promising biomarker for ICI therapy in NSCLC, with enhanced therapeutic stratification and management as a supplement to PD-L1 or TMB.